Number of Participants With an American College of Rheumatology (ACR) 20 Response at Week 12 Week 0 to Week 12 [clinicaltrials_resource:0ebe15dfa85ee272676de0da2bdeced1]
ACR 20 response is an improvement of greater than or equal to 20 percentage in both tender and swollen joint count and in 3 to 5 assessments (patient's assessment of pain visual analog scale [VAS] with 0, no pain to 10, worst pain; patient's and physician's global assessment of disease activity VAS scales: overall disease activity [0, very well to 10, very poor and 0, no arthritis activity to 10, extremely active, respectively]; Health Assessment Questionnaire [HAQ]: 20-questions on life activities [0, no difficulty to 3, inability to perform a task]; C-reactive protein[CRP]).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants With an American College of Rheumatology (ACR) 20 Response at Week 12 Week 0 to Week 12 [clinicaltrials_resource:0ebe15dfa85ee272676de0da2bdeced1]
ACR 20 response is an improvement of greater than or equal to 20 percentage in both tender and swollen joint count and in 3 to 5 assessments (patient's assessment of pain visual analog scale [VAS] with 0, no pain to 10, worst pain; patient's and physician's global assessment of disease activity VAS scales: overall disease activity [0, very well to 10, very poor and 0, no arthritis activity to 10, extremely active, respectively]; Health Assessment Questionnaire [HAQ]: 20-questions on life activities [0, no difficulty to 3, inability to perform a task]; C-reactive protein[CRP]).
Bio2RDF identifier
0ebe15dfa85ee272676de0da2bdeced1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0ebe15dfa85ee272676de0da2bdeced1
measure [clinicaltrials_vocabulary:measure]
Number of Participants With an ...... y (ACR) 20 Response at Week 12
time frame [clinicaltrials_vocabulary:time-frame]
Week 0 to Week 12
description
ACR 20 response is an improvem ...... sk]; C-reactive protein[CRP]).
identifier
clinicaltrials_resource:0ebe15dfa85ee272676de0da2bdeced1
title
Number of Participants With an ...... e at Week 12 Week 0 to Week 12
@en
type
label
Number of Participants With an ...... e15dfa85ee272676de0da2bdeced1]
@en